Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$159.85 +8.21 (+5.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Alnylam Pharmaceuticals (ALNY) Common Stock Issued (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Common Stock Issued of $33.56 million for Q2 2026, down 58.7% from $81.22 million a year earlier but up 155.1% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Common Stock Issued (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Common Stock Issued at Alnylam Pharmaceuticals was $166.16 million, down 39.6% year-over-year; for FY2025, it came in at $250.03 million, down 17.5% from FY2024.

  • Annual Common Stock Issued shows a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Common Stock Issued was $302.95 million in FY2024 (+105.4%), $147.46 million in FY2023 (-43.1%), $259.36 million in FY2022 (+5.3%) and $246.27 million in FY2021 (-17.9%).
  • Quarterly Common Stock Issued has run from a low of $13.16 million in Q1 2026 to a high of $153.02 million in Q3 2022 over five years.
  • On a year-over-year basis, Common Stock Issued increased in four of the last eight quarters, with growth averaging 32.5%.
  • The strongest year-over-year quarter for Common Stock Issued in the past five years was Q3 2024, with growth of 335.5%; the weakest was Q3 2023, with a decline of 83.8%.
  • According to Business Quant data, Common Stock Issued for the three prior quarters was $13.16 million (Q1 2026), $41.7 million (Q4 2025) and $77.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Alnylam Pharmaceuticals 20.30 Bn 7.49 Bn 1.10 Bn 15.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.47 Mn
Jun 30, 2026 33.56 Mn
Mar 31, 2026 13.16 Mn
Dec 31, 2025 41.70 Mn
Sep 30, 2025 77.74 Mn
Jun 30, 2025 81.22 Mn
Mar 31, 2025 49.37 Mn
Dec 31, 2024 36.28 Mn
Sep 30, 2024 108.04 Mn
Jun 30, 2024 132.78 Mn
Mar 31, 2024 25.86 Mn
Dec 31, 2023 30.89 Mn
Sep 30, 2023 24.81 Mn
Jun 30, 2023 49.39 Mn
Mar 31, 2023 42.37 Mn
Dec 31, 2022 56.71 Mn
Sep 30, 2022 153.02 Mn
Jun 30, 2022 22.50 Mn
Mar 31, 2022 27.12 Mn
Dec 31, 2021 45.04 Mn
API Access

Alnylam Pharmaceuticals Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ALNY&period=max&api_key=YOUR_API_KEY